Copyright Reports & Markets. All rights reserved.

Global Urology Drugs Market Research Report 2018 by Manufacturers, Regions, Types and Applications

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Urology Drugs Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance
      • 2.1.1 Product Type Market Performance (Volume)
      • 2.1.2 Product Type Market Performance (Value)
    • 2.2 China Urology Drugs Market Performance
    • 2.3 USA Urology Drugs Market Performance
    • 2.4 Europe Urology Drugs Market Performance
    • 2.5 Japan Urology Drugs Market Performance
    • 2.6 Korea Urology Drugs Market Performance
    • 2.7 India Urology Drugs Market Performance
    • 2.8 Southeast Asia Urology Drugs Market Performance
    • 2.9 South America Urology Drugs Market Performance

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
    • 3.2 China Urology Drugs Market Performance (Volume)
    • 3.3 USA Urology Drugs Market Performance (Volume)
    • 3.4 Europe Urology Drugs Market Performance (Volume)
    • 3.5 Japan Urology Drugs Market Performance (Volume)
    • 3.6 Korea Urology Drugs Market Performance (Volume)
    • 3.7 India Urology Drugs Market Performance (Volume)
    • 3.8 Southeast Asia Urology Drugs Market Performance (Volume)
    • 3.9 South America Urology Drugs Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Astellas
      • 4.1.1 Astellas Profiles
      • 4.1.2 Astellas Product Information
      • 4.1.3 Astellas Urology Drugs Business Performance
      • 4.1.4 Astellas Urology Drugs Business Development and Market Status
    • 4.2 Endo
      • 4.2.1 Endo Profiles
      • 4.2.2 Endo Product Information
      • 4.2.3 Endo Urology Drugs Business Performance
      • 4.2.4 Endo Urology Drugs Business Development and Market Status
    • 4.3 GP Pharm
      • 4.3.1 GP Pharm Profiles
      • 4.3.2 GP Pharm Product Information
      • 4.3.3 GP Pharm Urology Drugs Business Performance
      • 4.3.4 GP Pharm Urology Drugs Business Development and Market Status
    • 4.4 Tolmar
      • 4.4.1 Tolmar Profiles
      • 4.4.2 Tolmar Product Information
      • 4.4.3 Tolmar Urology Drugs Business Performance
      • 4.4.4 Tolmar Urology Drugs Business Development and Market Status
    • 4.20

    5 Market Performance for Manufacturers

    • 5.1 Global Urology Drugs Production (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Global Urology Drugs Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Global Urology Drugs Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Global Urology Drugs Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Global Urology Drugs Market Performance (Production Point)

    • 6.1 Global Urology Drugs Production (K Units) and Market Share by Regions 2013-2018
    • 6.2 Global Urology Drugs Revenue (M USD) and Market Share by Regions 2013-2018
    • 6.3 Global Urology Drugs Price (USD/Unit) by Regions 2013-2018
    • 6.4 Global Urology Drugs Gross Margin by Regions 2013-2018

    7 Development Trend for Regions (Production Point)

    • 7.1 Global Urology Drugs Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
    • 7.2 China Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.3 USA Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.4 Europe Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.5 Japan Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.6 Korea Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.7 India Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.8 Southeast Asia Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.9 South America Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

    8 Global Urology Drugs Market Performance (Consumption Point)

    • 8.1 Global Urology Drugs Consumption and Market Share by Regions 2013-2018
    • 8.2 Global Urology Drugs Consumption Value and Market Share by Regions 2013-2018
    • 8.3 Global Urology Drugs Price (USD/Unit) by Regions 2013-2018

    9 Development Trend for Regions (Sales Point)

    • 9.1 Global Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.2 China Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.3 USA Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.4 Europe Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.5 Japan Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.6 Korea Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.7 India Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.8 Southeast Asia Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.9 South America Urology Drugs Sales and Growth, Sales Value and Growth Rate2013-2018

    10 Upstream Source, Technology and Cost

    • 10.1 Upstream Source
    • 10.2 Technology
    • 10.3 Cost

    11 Channel Analysis

    • 11.1 Market Channel
    • 11.2 Distributors

    12 Consumer Analysis

    • 12.1 Hospital Industry
    • 12.2 Clinic Industry

    13 Market Forecast 2019-2024

    • 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 13.1.1 Global Urology Drugs Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 13.1.2 Global Urology Drugs Production (K Units) and Growth Rate 2019-2024
      • 13.1.3 China Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.4 USA Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.5 Europe Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.6 Japan Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.7 Korea Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.8 India Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.9 Southeast Asia Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.10 South America Urology Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 13.2 Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.1 Global Urology Drugs Consumption and Market Share by Regions 2019-2024
      • 13.2.2 Global Urology Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.3 China Urology Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.4 USA Urology Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.5 Europe Urology Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.6 Japan Urology Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.7 Korea Urology Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.8 India Urology Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.9 Southeast Asia Urology Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.10 South America Urology Drugs Sales, Sales Value and Growth Rate 2019-2024
    • 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
      • 13.3.1 Overall Market Performance
      • 13.3.2 α (alpha) - blockers Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.3.3 5 α-reductase inhibitors Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 13.4 Sales by Application 2019-2024
      • 13.4.1 Overall Market Performance
      • 13.4.2 Hospital Sales and and Growth Rate 2019-2024
      • 13.4.3 Clinic Sales and and Growth Rate 2019-2024
    • 13.5 Price (USD/Unit) and Gross Profit
      • 13.5.1 Global Urology Drugs Price (USD/Unit) Trend 2019-2024
      • 13.5.2 Global Urology Drugs Gross Profit Trend 2019-2024

    14 Conclusion

    Geographically, global Urology Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Astellas
    Endo
    GP Pharm
    Tolmar

    On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
    α (alpha) - blockers
    5 α-reductase inhibitors
    For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Urology Drugs for each application, including
    Hospital
    Clinic
    Production, consumption, revenue, market share and growth rate are the key targets for Urology Drugs from 2013 to 2024 (forecast) in these regions
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now